Developing and Refining New Candidate Criteria for Systemic Lupus Erythematosus Classification: An International Collaboration

Arthritis Care and Research

Volumn 70, Issue 4, 2018, Pages 571-581

  Tedeschi, Sara K ^a   Johnson, Sindhu R ^b   Boumpas, Dimitrios ^c   Daikh, David ^d   Dörner, Thomas ^e   Jayne, David ^f   Kamen, Diane ^g   Lerstrøm, Kirsten ^h   Mosca, Marta ⁱ   Ramsey Goldman, Rosalind ^j   Sinnette, Corine ^a   Wofsy, David ^d   Smolen, Josef S ^k   Naden, Raymond P ^l   Aringer, Martin ^m   Costenbader, Karen H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CRETE   (Greece)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h LUPUS EUROPE   (Denmark)

ⁱ UNIVERSITY OF PISA   (Italy)

^j NORTHWESTERN UNIVERSITY   (United States)

^k MEDICAL UNIVERSITY OF VIENNA   (Austria)

^l MCMASTER UNIVERSITY   (Canada)

^m UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; PHOSPHOLIPID ANTIBODY; BIOLOGICAL MARKER; COMPLEMENT;

ALOPECIA; ANTIBODY DETECTION; ANTIBODY TITER; ARTHRITIS; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CEREBROVASCULAR ACCIDENT; CHOREA; CLINICAL EVALUATION; CONFUSION; CONSENSUS DEVELOPMENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FEVER; HEP-2 CELL LINE; HUMAN; IMMUNOFLUORESCENCE; INFLAMMATION; INTERNATIONAL COOPERATION; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; MEDICAL DECISION MAKING; MOUTH LESION; MYELITIS; OPTIC NEURITIS; PROBABILITY; PROTEINURIA; PSYCHOSIS; RASH; SEIZURE; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; BLOOD; CLASSIFICATION; CLINICAL TRIAL; CONSENSUS; DELPHI STUDY; EUROPE; IMMUNOLOGY; MULTICENTER STUDY; NOMENCLATURE; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; UNITED STATES;

ANTIBODIES, ANTINUCLEAR; BIOMARKERS; COMPLEMENT SYSTEM PROTEINS; CONSENSUS; DELPHI TECHNIQUE; EUROPE; HUMANS; INTERNATIONAL COOPERATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TERMINOLOGY AS TOPIC; UNITED STATES;

EID: 85042388899     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.23317     Document Type: Article

References (38)

1. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
2. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
3. Aringer M, Dorner T, Leuchten N, Johnson SR. Toward new criteria for systemic lupus erythematosus: a standpoint. Lupus 2016;25:805–11.
4. Felson DT, Anderson JJ. Methodological and statistical approaches to criteria development in rheumatic diseases. Baillieres Clin Rheumatol 1995;9:253–66.
5. Singh JA, Solomon DH, Dougados M, Felson D, Hawker G, Katz P, et al. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006;55:348–52.
6. Dougados M, Gossec L. Classification criteria for rheumatic diseases: why and how? Arthritis Rheum 2007;57:1112–5.
7. Johnson SR, Goek ON, Singh-Grewal D, Vlad SC, Feldman BM, Felson DT, et al. Classification criteria in rheumatic diseases: a review of methodologic properties. Arthritis Rheum 2007;57:1119–33.
8. Schmajuk G, Hoyer BF, Aringer M, Johnson SR, Dorner T, Daikh DI. Identification of candidate items for revised classification criteria for systemic lupus erythematosus [abstract]. Arthritis Rheum 2015;67 Suppl 10.
9. Hoyer BF, Schmajuk G, Aringer M, Johnson SR, Daikh DI, Dorner T. Multi-center Delphi exercise reveals important key items in classifying SLE [abstract]. Arthritis Rheum 2015;67 Suppl 10.
10. Johnson SR, Khanna D, Cervera R, Costedoat-Chalumeau N, Gladman DD, Hahn BH, et al. Use of nominal group technique to determine candidate items for SLE classification criteria development [abstract]. Arthritis Rheum 2016;68 Suppl 10.
11. Leuchten N, Schoels M, Smolen J, Aringer M, Johnson SR, Daikh DI, et al. Performance of anti-nuclear antibodies for classifying systemic lupus erythematosus: a systematic literature review and meta-regression of diagnostic data. Arthritis Care Res (Hoboken). 2018;70:428–38.
12. Johnson SR, Fransen J, Khanna D, Baron M, van den Hoogen F, Medsger TA Jr, et al. Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res (Hoboken) 2012;64:358–67.
13. Johnson SR, Naden RP, Fransen J, van den Hoogen F, Pope JE, Baron M, et al. Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria. J Clin Epidemiol 2014;67:706–14.
14. Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737–47.
15. Neogi T, Aletaha D, Silman AJ, Naden RL, Felson DT, Aggarwal R, et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum 2010;62:2582–91.
16. Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, et al. 2015 gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2015;67:2557–68.
17. Cohen AS, Reynolds WE, Franklin EC, Kulka JP, Ropes MW, Shulman LE, et al. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 1971;21:643–48.
18. Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677–86.
19. Touma Z, Costenbader KH, Johnson SR, Hoyer BF, Navara S, Bonfa E, et al. Do patients with SLE at onset differ from mimickers? A comparison of clinical and serological manifestations in a multicenter cohort to inform the development of new classification criteria for SLE [abstract]. Ann Rheum Dis 2016;75 Suppl 2:558.
20. Li H, Lin S, Yang S, Chen L, Zheng X. Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus. Clin Rheum 2015;34:471–7.
21. Petersdorf RG. Fever of unknown origin: an old friend revisited [editorial]. Arch Int Med 1992;152:21–2.
22. Cervera R, Khamashta M, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. Medicine (Baltimore) 1999;78:167–75.
23. Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 1981;4:471–5.
24. Elman SA, Joyce C, Nyberg F, Furukawa F, Goodfield M, Hasegawa M, et al. Development of classification criteria in discoid lupus erythematosus: results of a consensus exercise. J Am Acad Dermatol 2017;77:261–7.
25. Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Wallace DJ, et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2010;69:529–35.
26. Zirkzee EJ, Magro Checa C, Sohrabian A, Steup-Beekman GM. Cluster analysis of an array of autoantibodies in neuropsychiatric systemic lupus erythematosus [letter]. J Rheumatol 2014;41:1720–1.
27. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599–608.
28. Adler Y, Charron P, Imazio M, Badano L, Baron-Esquivias G, Bogaert J, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Eur Heart J 2015;36:2921–64.
29. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65:521–30.
30. Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006;54:421–32.
31. Dall'Era M, Cisternas MG, Smilek DE, Straub L, Houssiau FA, Cervera R, et al. Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis Cohort. Arthritis Rheum 2015;67:1305–13.
32. Miyakis S, Lockshin M, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295–306.
33. Hanly JG, Urowitz MB, Sanchez-Guerrero J, Bae SC, Gordon C, Wallace DJ, et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 2007;56:265–73.
34. Aberle T, Bourn RL, Munroe ME, Chen H, Roberts VC, Guthridge JM, et al. Clinical and serologic features in patients with incomplete lupus classification versus systemic lupus erythematosus patients and controls. Arthritis Care Res (Hoboken) 2017;69:1780–8.
35. Munroe ME, Young KA, Kamen DL, Guthridge JM, Niewold TB, Costenbader KH, et al. Discerning risk of disease transition in relatives of systemic lupus erythematosus patients utilizing soluble mediators and clinical features. Arthritis Rheum 2017;69:630–42.
36. Lu R, Munroe ME, Guthridge JM, Bean KM, Fife DA, Chen H, et al. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. J Autoimmun 2016;74:182–93.
37. Putterman C, Furie R, Ramsey-Goldman R, Askanase A, Buyon J, Kalunian K, et al. Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements. Lupus Sci Med 2014;1:e000056.
38. Hanly JG, McCurdy G, Fougere L, Douglas J, Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004;31:2156–62.